279 related articles for article (PubMed ID: 30771597)
1. The detection of BKPyV genotypes II and IV after renal transplantation as a simple tool for risk assessment for PyVAN and transplant outcome already at early stages of BKPyV reactivation.
Korth J; Anastasiou OE; Bräsen JH; Brinkhoff A; Lehmann U; Kribben A; Dittmer U; Verheyen J; Wilde B; Ciesek S; Witzke O; Widera M
J Clin Virol; 2019 Apr; 113():14-19. PubMed ID: 30771597
[TBL] [Abstract][Full Text] [Related]
2. Impact of HMG-CoA reductase inhibitors on the incidence of polyomavirus-associated nephropathy in renal transplant recipients with human BK polyomavirus viremia.
Gabardi S; Ramasamy S; Kim M; Klasek R; Carter D; Mackenzie MR; Chandraker A; Tan CS
Transpl Infect Dis; 2015 Aug; 17(4):536-43. PubMed ID: 25989423
[TBL] [Abstract][Full Text] [Related]
3. Early fulminant BK polyomavirus-associated nephropathy in two kidney transplant patients with low neutralizing antibody titers receiving allografts from the same donor.
Lorentzen EM; Henriksen S; Kaur A; Kro GB; Hammarström C; Hirsch HH; Midtvedt K; Rinaldo CH
Virol J; 2020 Jan; 17(1):5. PubMed ID: 31924245
[TBL] [Abstract][Full Text] [Related]
4. BK Polyomavirus-associated nephropathy managed by screening policy in a real-life setting.
Raupp FVV; Meinerz G; da Silva CK; Bianco PCD; Goldani JC; Pegas KL; Stolfo JB; Garcia VD; Keitel E
Transpl Infect Dis; 2020 Feb; 22(1):e13213. PubMed ID: 31724282
[TBL] [Abstract][Full Text] [Related]
5. BK polyomavirus microRNA expression and sequence variation in polyomavirus-associated nephropathy.
Virtanen E; Seppälä H; Helanterä I; Laine P; Lautenschlager I; Paulin L; Mannonen L; Auvinen P; Auvinen E
J Clin Virol; 2018 May; 102():70-76. PubMed ID: 29518695
[TBL] [Abstract][Full Text] [Related]
6. Nephrotoxicity of calcineurin inhibitors as a risk factor for BK polyomavirus replication after kidney transplantation.
Krejčí K; Tichý T; Bednaříková J; Bartková M; Žamboch K; Orság J; Zadražil J
J Med Virol; 2021 Jun; 93(6):3871-3879. PubMed ID: 32940913
[TBL] [Abstract][Full Text] [Related]
7. Impact of low-level BK polyomavirus viremia on intermediate-term renal allograft function.
Korth J; Widera M; Dolff S; Guberina H; Bienholz A; Brinkhoff A; Anastasiou OE; Kribben A; Dittmer U; Verheyen J; Wilde B; Witzke O
Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29156086
[TBL] [Abstract][Full Text] [Related]
8. Prediction of BK viremia by urine viral load in renal transplant patients: An analysis of BK viral load results in paired urine and plasma samples.
Madden K; Janitell C; Sower D; Yang S
Transpl Infect Dis; 2018 Oct; 20(5):e12952. PubMed ID: 29896858
[TBL] [Abstract][Full Text] [Related]
9. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
[TBL] [Abstract][Full Text] [Related]
10. Early identification of renal transplant recipients with high risk of polyomavirus-associated nephropathy.
Teutsch K; Schweitzer F; Knops E; Kaiser R; Pfister H; Verheyen J; Göbel H; Cingöz T; Di Cristanziano V
Med Microbiol Immunol; 2015 Dec; 204(6):657-64. PubMed ID: 25749892
[TBL] [Abstract][Full Text] [Related]
11. Determination of viremia cut-off for risk to develop BKPyV-associated nephropathy among kidney transplant recipients.
Bicalho CS; Oliveira RDR; David DR; Fink MCDS; Agena F; Castro MC; Panutti C; David-Neto E; Pierrotti LC
Transpl Infect Dis; 2018 Oct; 20(5):e12969. PubMed ID: 30074295
[TBL] [Abstract][Full Text] [Related]
12. Variable sources of Bk virus in renal allograft recipients.
Urbano PRP; Nali LHDS; Oliveira RDR; Sumita LM; Fink MCDDS; Pierrotti LC; Bicalho CDS; David-Neto E; Pannuti CS; Romano CM
J Med Virol; 2019 Jun; 91(6):1136-1141. PubMed ID: 30680753
[TBL] [Abstract][Full Text] [Related]
13. Urine Donor-Derived Cell-Free DNA Helps Discriminate BK Polyomavirus-Associated Nephropathy in Kidney Transplant Recipients With BK Polyomavirus Infection.
Chen XT; Chen WF; Li J; Deng RH; Huang Y; Yang SC; Chen PS; Jiang TY; Liu HT; Wang CX; Chen LZ; Qiu J; Huang G
Front Immunol; 2020; 11():1763. PubMed ID: 32973745
[No Abstract] [Full Text] [Related]
14. BK polyomavirus viremia and antibody responses of pediatric kidney transplant recipients in Finland.
Miettinen J; Lautenschlager I; Weissbach F; Wernli M; Auvinen E; Mannonen L; Lauronen J; Hirsch HH; Jalanko H
Pediatr Transplant; 2019 Feb; 23(1):e13324. PubMed ID: 30447046
[TBL] [Abstract][Full Text] [Related]
15. Detection of BK polyomavirus genotypes to predict the development of BK polyomavirus-associated complications in kidney transplant recipients: A retrospective analysis.
Muñoz-Gallego I; Díaz-Madridano N; Moral N; Pascual C; Polanco N; González E; Andrés A; Folgueira MD
Transpl Infect Dis; 2021 Aug; 23(4):e13615. PubMed ID: 33866657
[TBL] [Abstract][Full Text] [Related]
16. Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation.
Grellier J; Hirsch HH; Mengelle C; Esposito L; Hebral AL; Bellière J; Weissbach F; Izopet J; Del Bello A; Kamar N
Transpl Infect Dis; 2018 Aug; 20(4):e12917. PubMed ID: 29800505
[TBL] [Abstract][Full Text] [Related]
17. Multiplex analysis of Human Polyomavirus diversity in kidney transplant recipients with BK virus replication.
Wang Y; Strassl R; Helanterä I; Aberle SW; Bond G; Hedman K; Weseslindtner L
J Clin Virol; 2019 Nov; 120():6-11. PubMed ID: 31505316
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of polyoma BK virus infection among living-donor renal transplant recipients.
El Ansary M; Abd Elhamid S; Saadi G; Ismail W; Ibrahim N; Bahaa El-Din N; Alhsyek S
Transpl Infect Dis; 2016 Aug; 18(4):529-37. PubMed ID: 27226063
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and outcomes of late-onset BK virus nephropathy in kidney and kidney-pancreas transplant recipients.
Imlay H; Whitaker K; Fisher CE; Limaye AP
Transpl Infect Dis; 2018 Aug; 20(4):e12928. PubMed ID: 29809315
[TBL] [Abstract][Full Text] [Related]
20. MICA Mutant A5.1 Influences BK Polyomavirus Reactivation and Associated Nephropathy After Kidney Transplantation.
Tonnerre P; Gérard N; Gavlovsky PJ; Mazalrey S; Hourmant M; Cheneau ML; Cesbron-Gautier A; Renaudin K; Bressollette-Bodin C; Charreau B
J Infect Dis; 2016 Sep; 214(5):807-16. PubMed ID: 27130430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
